Qiagen Explores Possible Sale After New Buyer Talks: Report

German life sciences tools company Qiagen N.V. (NYSE:QGEN) is reportedly reviewing strategic options, including a potential sale, as renewed takeover interest emerges.The European molecular diagnostics company has engaged advisers while its supervisory board evaluates early-stage approaches from potential suitors, Bloomberg reported on Tuesday, signaling a possible shift after several failed attempts to strike a deal in recent years.Citing people with knowledge of the discussions, the report highlighted tha ...